最新发布
Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer
Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s two lead programs, and expanding its indications under study after seeing early signs of clinical activity.
覆盖320万英亩、年产值约4200万美元:丁硫克百威在印度面临全面禁用
世界农化网中文网报道:近日,印度中央政府提议禁用广泛使用的杀虫剂丁硫克百威(carbosulfan),理由是该成分对人类和动物健康存在潜在毒性风险,且一旦发生意外中毒事件,目前尚无已知的特效解毒剂。
中国新化学农药原药生态毒理资料要求修订及登记难点剖析
世界农化网中文网报道:2026年7月31日,农业农村部种植业管理司就修订《农药登记资料要求》公开征求意见。与2017年现行要求相比,修订稿调整了新化学农药原药的鸟类、水生生物、底栖生物和土壤生物资料,提高了繁殖和慢性效应资料在长期风险评价中的比重。本次公布内容仍为征求意见稿,最终文本及实施口径以农业农村部后续正式文件和农业农村部农药检定所的进一步说明为准。
Multi-Academic Study Finds No Link Between Pesticide Exposure and Autism Traits
Prenatal exposure to certain insecticides used in agriculture does not appear to be linked to social communication problems and other traits related to autism, according to a new study, “Prenatal Organophosphate Exposure and Autism-Related Traits in Children,” published in JAMA Pediatrics.
U.S.-Canada Tariff Dispute Raises Fresh Risks for Agriculture
August 2026, Washington: The latest escalation in the U.S.-Canada trade dispute is adding another layer of uncertainty f…
Äio, TFTAK Get $2.6M from Estonian Govt to Enhance Waste-Fermented Yeast Fat Production
Estonian biotech company Äio and applied research organisation TFTAK have launched a new R&D project to develop a digitalised production platform for waste-derived microbial oils.
三大创新产品强劲增长,先正达集团实现营收122亿美元
❖ 2026年上半年集团营业收入为122亿美元1,同比下降2%(按固定汇率计下降7%),主要受业务重组及聚焦高质量业务战略的影响; &…
利民股份:核心产品显著增长,头部地位持续巩固
近日,利民控股集团股份有限公司(002734.SZ;简称“利民股份”)发布2026年半年度报告。面对农化行业价格下行、成本上涨及需求放缓等多重挑战,…
